Global Regenerative Medicine Market Insights, Forecast to 2029
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Application
1.3.1 Global Regenerative Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Medicine Market Perspective (2018-2029)
2.2 Global Regenerative Medicine Growth Trends by Region
2.2.1 Regenerative Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Regenerative Medicine Historic Market Size by Region (2018-2023)
2.2.3 Regenerative Medicine Forecasted Market Size by Region (2024-2029)
2.3 Regenerative Medicine Market Dynamics
2.3.1 Regenerative Medicine Industry Trends
2.3.2 Regenerative Medicine Market Drivers
2.3.3 Regenerative Medicine Market Challenges
2.3.4 Regenerative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Regenerative Medicine by Players
3.1.1 Global Regenerative Medicine Revenue by Players (2018-2023)
3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Regenerative Medicine, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Regenerative Medicine Market Concentration Ratio
3.4.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2022
3.5 Global Key Players of Regenerative Medicine Head office and Area Served
3.6 Global Key Players of Regenerative Medicine, Product and Application
3.7 Global Key Players of Regenerative Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Medicine Breakdown Data by Type
4.1 Global Regenerative Medicine Historic Market Size by Type (2018-2023)
4.2 Global Regenerative Medicine Forecasted Market Size by Type (2024-2029)
5 Regenerative Medicine Breakdown Data by Application
5.1 Global Regenerative Medicine Historic Market Size by Application (2018-2023)
5.2 Global Regenerative Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Regenerative Medicine Market Size (2018-2029)
6.2 North America Regenerative Medicine Market Size by Type
6.2.1 North America Regenerative Medicine Market Size by Type (2018-2023)
6.2.2 North America Regenerative Medicine Market Size by Type (2024-2029)
6.2.3 North America Regenerative Medicine Market Share by Type (2018-2029)
6.3 North America Regenerative Medicine Market Size by Application
6.3.1 North America Regenerative Medicine Market Size by Application (2018-2023)
6.3.2 North America Regenerative Medicine Market Size by Application (2024-2029)
6.3.3 North America Regenerative Medicine Market Share by Application (2018-2029)
6.4 North America Regenerative Medicine Market Size by Country
6.4.1 North America Regenerative Medicine Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Regenerative Medicine Market Size by Country (2018-2023)
6.4.3 North America Regenerative Medicine Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Regenerative Medicine Market Size (2018-2029)
7.2 Europe Regenerative Medicine Market Size by Type
7.2.1 Europe Regenerative Medicine Market Size by Type (2018-2023)
7.2.2 Europe Regenerative Medicine Market Size by Type (2024-2029)
7.2.3 Europe Regenerative Medicine Market Share by Type (2018-2029)
7.3 Europe Regenerative Medicine Market Size by Application
7.3.1 Europe Regenerative Medicine Market Size by Application (2018-2023)
7.3.2 Europe Regenerative Medicine Market Size by Application (2024-2029)
7.3.3 Europe Regenerative Medicine Market Share by Application (2018-2029)
7.4 Europe Regenerative Medicine Market Size by Country
7.4.1 Europe Regenerative Medicine Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Regenerative Medicine Market Size by Country (2018-2023)
7.4.3 Europe Regenerative Medicine Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Regenerative Medicine Market Size (2018-2029)
8.2 China Regenerative Medicine Market Size by Type
8.2.1 China Regenerative Medicine Market Size by Type (2018-2023)
8.2.2 China Regenerative Medicine Market Size by Type (2024-2029)
8.2.3 China Regenerative Medicine Market Share by Type (2018-2029)
8.3 China Regenerative Medicine Market Size by Application
8.3.1 China Regenerative Medicine Market Size by Application (2018-2023)
8.3.2 China Regenerative Medicine Market Size by Application (2024-2029)
8.3.3 China Regenerative Medicine Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Regenerative Medicine Market Size (2018-2029)
9.2 Asia Regenerative Medicine Market Size by Type
9.2.1 Asia Regenerative Medicine Market Size by Type (2018-2023)
9.2.2 Asia Regenerative Medicine Market Size by Type (2024-2029)
9.2.3 Asia Regenerative Medicine Market Share by Type (2018-2029)
9.3 Asia Regenerative Medicine Market Size by Application
9.3.1 Asia Regenerative Medicine Market Size by Application (2018-2023)
9.3.2 Asia Regenerative Medicine Market Size by Application (2024-2029)
9.3.3 Asia Regenerative Medicine Market Share by Application (2018-2029)
9.4 Asia Regenerative Medicine Market Size by Region
9.4.1 Asia Regenerative Medicine Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Regenerative Medicine Market Size by Region (2018-2023)
9.4.3 Asia Regenerative Medicine Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Regenerative Medicine Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Regenerative Medicine Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Regenerative Medicine Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 J & J (DePuy Synthes)
11.1.1 J & J (DePuy Synthes) Company Details
11.1.2 J & J (DePuy Synthes) Business Overview
11.1.3 J & J (DePuy Synthes) Regenerative Medicine Introduction
11.1.4 J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2018-2023)
11.1.5 J & J (DePuy Synthes) Recent Developments
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Regenerative Medicine Introduction
11.2.4 Medtronic Revenue in Regenerative Medicine Business (2018-2023)
11.2.5 Medtronic Recent Developments
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Regenerative Medicine Introduction
11.3.4 Zimmer Biomet Revenue in Regenerative Medicine Business (2018-2023)
11.3.5 Zimmer Biomet Recent Developments
11.4 Stryker
11.4.1 Stryker Company Details
11.4.2 Stryker Business Overview
11.4.3 Stryker Regenerative Medicine Introduction
11.4.4 Stryker Revenue in Regenerative Medicine Business (2018-2023)
11.4.5 Stryker Recent Developments
11.5 Allergan(Acelity)
11.5.1 Allergan(Acelity) Company Details
11.5.2 Allergan(Acelity) Business Overview
11.5.3 Allergan(Acelity) Regenerative Medicine Introduction
11.5.4 Allergan(Acelity) Revenue in Regenerative Medicine Business (2018-2023)
11.5.5 Allergan(Acelity) Recent Developments
11.6 MiMedx Group
11.6.1 MiMedx Group Company Details
11.6.2 MiMedx Group Business Overview
11.6.3 MiMedx Group Regenerative Medicine Introduction
11.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2018-2023)
11.6.5 MiMedx Group Recent Developments
11.7 Organogenesis
11.7.1 Organogenesis Company Details
11.7.2 Organogenesis Business Overview
11.7.3 Organogenesis Regenerative Medicine Introduction
11.7.4 Organogenesis Revenue in Regenerative Medicine Business (2018-2023)
11.7.5 Organogenesis Recent Developments
11.8 Fujifilm Cellular Dynamics
11.8.1 Fujifilm Cellular Dynamics Company Details
11.8.2 Fujifilm Cellular Dynamics Business Overview
11.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Introduction
11.8.4 Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2018-2023)
11.8.5 Fujifilm Cellular Dynamics Recent Developments
11.9 Osiris Therapeutics
11.9.1 Osiris Therapeutics Company Details
11.9.2 Osiris Therapeutics Business Overview
11.9.3 Osiris Therapeutics Regenerative Medicine Introduction
11.9.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2018-2023)
11.9.5 Osiris Therapeutics Recent Developments
11.10 Vcanbio
11.10.1 Vcanbio Company Details
11.10.2 Vcanbio Business Overview
11.10.3 Vcanbio Regenerative Medicine Introduction
11.10.4 Vcanbio Revenue in Regenerative Medicine Business (2018-2023)
11.10.5 Vcanbio Recent Developments
11.11 CCBC
11.11.1 CCBC Company Details
11.11.2 CCBC Business Overview
11.11.3 CCBC Regenerative Medicine Introduction
11.11.4 CCBC Revenue in Regenerative Medicine Business (2018-2023)
11.11.5 CCBC Recent Developments
11.12 Cytori
11.12.1 Cytori Company Details
11.12.2 Cytori Business Overview
11.12.3 Cytori Regenerative Medicine Introduction
11.12.4 Cytori Revenue in Regenerative Medicine Business (2018-2023)
11.12.5 Cytori Recent Developments
11.13 Celgene
11.13.1 Celgene Company Details
11.13.2 Celgene Business Overview
11.13.3 Celgene Regenerative Medicine Introduction
11.13.4 Celgene Revenue in Regenerative Medicine Business (2018-2023)
11.13.5 Celgene Recent Developments
11.14 Vericel Corporation
11.14.1 Vericel Corporation Company Details
11.14.2 Vericel Corporation Business Overview
11.14.3 Vericel Corporation Regenerative Medicine Introduction
11.14.4 Vericel Corporation Revenue in Regenerative Medicine Business (2018-2023)
11.14.5 Vericel Corporation Recent Developments
11.15 Guanhao Biotech
11.15.1 Guanhao Biotech Company Details
11.15.2 Guanhao Biotech Business Overview
11.15.3 Guanhao Biotech Regenerative Medicine Introduction
11.15.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2018-2023)
11.15.5 Guanhao Biotech Recent Developments
11.16 Mesoblast
11.16.1 Mesoblast Company Details
11.16.2 Mesoblast Business Overview
11.16.3 Mesoblast Regenerative Medicine Introduction
11.16.4 Mesoblast Revenue in Regenerative Medicine Business (2018-2023)
11.16.5 Mesoblast Recent Developments
11.17 AMAG Pharmaceuticals (CBR)
11.17.1 AMAG Pharmaceuticals (CBR) Company Details
11.17.2 AMAG Pharmaceuticals (CBR) Business Overview
11.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Introduction
11.17.4 AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2018-2023)
11.17.5 AMAG Pharmaceuticals (CBR) Recent Developments
11.18 ViaCord
11.18.1 ViaCord Company Details
11.18.2 ViaCord Business Overview
11.18.3 ViaCord Regenerative Medicine Introduction
11.18.4 ViaCord Revenue in Regenerative Medicine Business (2018-2023)
11.18.5 ViaCord Recent Developments
11.19 CordLife
11.19.1 CordLife Company Details
11.19.2 CordLife Business Overview
11.19.3 CordLife Regenerative Medicine Introduction
11.19.4 CordLife Revenue in Regenerative Medicine Business (2018-2023)
11.19.5 CordLife Recent Developments
11.20 Integra LifeSciences
11.20.1 Integra LifeSciences Company Details
11.20.2 Integra LifeSciences Business Overview
11.20.3 Integra LifeSciences Regenerative Medicine Introduction
11.20.4 Integra LifeSciences Revenue in Regenerative Medicine Business (2018-2023)
11.20.5 Integra LifeSciences Recent Developments
11.21 Nuvasive
11.21.1 Nuvasive Company Details
11.21.2 Nuvasive Business Overview
11.21.3 Nuvasive Regenerative Medicine Introduction
11.21.4 Nuvasive Revenue in Regenerative Medicine Business (2018-2023)
11.21.5 Nuvasive Recent Developments
11.22 Cook Biotech
11.22.1 Cook Biotech Company Details
11.22.2 Cook Biotech Business Overview
11.22.3 Cook Biotech Regenerative Medicine Introduction
11.22.4 Cook Biotech Revenue in Regenerative Medicine Business (2018-2023)
11.22.5 Cook Biotech Recent Developments
11.23 Japan Tissue Engineering
11.23.1 Japan Tissue Engineering Company Details
11.23.2 Japan Tissue Engineering Business Overview
11.23.3 Japan Tissue Engineering Regenerative Medicine Introduction
11.23.4 Japan Tissue Engineering Revenue in Regenerative Medicine Business (2018-2023)
11.23.5 Japan Tissue Engineering Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Tissue Engineering
Table 4. Key Players of Biomaterial
Table 5. Key Players of Other
Table 6. Global Regenerative Medicine Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Regenerative Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Regenerative Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Regenerative Medicine Market Share by Region (2018-2023)
Table 10. Global Regenerative Medicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Regenerative Medicine Market Share by Region (2024-2029)
Table 12. Regenerative Medicine Market Trends
Table 13. Regenerative Medicine Market Drivers
Table 14. Regenerative Medicine Market Challenges
Table 15. Regenerative Medicine Market Restraints
Table 16. Global Regenerative Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Regenerative Medicine Revenue Share by Players (2018-2023)
Table 18. Global Top Regenerative Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2022)
Table 19. Global Regenerative Medicine Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Regenerative Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Regenerative Medicine, Headquarters and Area Served
Table 22. Global Key Players of Regenerative Medicine, Product and Application
Table 23. Global Key Players of Regenerative Medicine, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Regenerative Medicine Revenue Market Share by Type (2018-2023)
Table 27. Global Regenerative Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Regenerative Medicine Revenue Market Share by Type (2024-2029)
Table 29. Global Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Regenerative Medicine Revenue Share by Application (2018-2023)
Table 31. Global Regenerative Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Regenerative Medicine Revenue Share by Application (2024-2029)
Table 33. North America Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Regenerative Medicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Regenerative Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Regenerative Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Regenerative Medicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Regenerative Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Regenerative Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Regenerative Medicine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Regenerative Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Regenerative Medicine Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Regenerative Medicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 65. J & J (DePuy Synthes) Company Details
Table 66. J & J (DePuy Synthes) Business Overview
Table 67. J & J (DePuy Synthes) Regenerative Medicine Product
Table 68. J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 69. J & J (DePuy Synthes) Recent Developments
Table 70. Medtronic Company Details
Table 71. Medtronic Business Overview
Table 72. Medtronic Regenerative Medicine Product
Table 73. Medtronic Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 74. Medtronic Recent Developments
Table 75. Zimmer Biomet Company Details
Table 76. Zimmer Biomet Business Overview
Table 77. Zimmer Biomet Regenerative Medicine Product
Table 78. Zimmer Biomet Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 79. Zimmer Biomet Recent Developments
Table 80. Stryker Company Details
Table 81. Stryker Business Overview
Table 82. Stryker Regenerative Medicine Product
Table 83. Stryker Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 84. Stryker Recent Developments
Table 85. Allergan(Acelity) Company Details
Table 86. Allergan(Acelity) Business Overview
Table 87. Allergan(Acelity) Regenerative Medicine Product
Table 88. Allergan(Acelity) Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 89. Allergan(Acelity) Recent Developments
Table 90. MiMedx Group Company Details
Table 91. MiMedx Group Business Overview
Table 92. MiMedx Group Regenerative Medicine Product
Table 93. MiMedx Group Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 94. MiMedx Group Recent Developments
Table 95. Organogenesis Company Details
Table 96. Organogenesis Business Overview
Table 97. Organogenesis Regenerative Medicine Product
Table 98. Organogenesis Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 99. Organogenesis Recent Developments
Table 100. Fujifilm Cellular Dynamics Company Details
Table 101. Fujifilm Cellular Dynamics Business Overview
Table 102. Fujifilm Cellular Dynamics Regenerative Medicine Product
Table 103. Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 104. Fujifilm Cellular Dynamics Recent Developments
Table 105. Osiris Therapeutics Company Details
Table 106. Osiris Therapeutics Business Overview
Table 107. Osiris Therapeutics Regenerative Medicine Product
Table 108. Osiris Therapeutics Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 109. Osiris Therapeutics Recent Developments
Table 110. Vcanbio Company Details
Table 111. Vcanbio Business Overview
Table 112. Vcanbio Regenerative Medicine Product
Table 113. Vcanbio Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 114. Vcanbio Recent Developments
Table 115. CCBC Company Details
Table 116. CCBC Business Overview
Table 117. CCBC Regenerative Medicine Product
Table 118. CCBC Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 119. CCBC Recent Developments
Table 120. Cytori Company Details
Table 121. Cytori Business Overview
Table 122. Cytori Regenerative Medicine Product
Table 123. Cytori Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 124. Cytori Recent Developments
Table 125. Celgene Company Details
Table 126. Celgene Business Overview
Table 127. Celgene Regenerative Medicine Product
Table 128. Celgene Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 129. Celgene Recent Developments
Table 130. Vericel Corporation Company Details
Table 131. Vericel Corporation Business Overview
Table 132. Vericel Corporation Regenerative Medicine Product
Table 133. Vericel Corporation Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 134. Vericel Corporation Recent Developments
Table 135. Guanhao Biotech Company Details
Table 136. Guanhao Biotech Business Overview
Table 137. Guanhao Biotech Regenerative Medicine Product
Table 138. Guanhao Biotech Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 139. Guanhao Biotech Recent Developments
Table 140. Mesoblast Company Details
Table 141. Mesoblast Business Overview
Table 142. Mesoblast Regenerative Medicine Product
Table 143. Mesoblast Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 144. Mesoblast Recent Developments
Table 145. AMAG Pharmaceuticals (CBR) Company Details
Table 146. AMAG Pharmaceuticals (CBR) Business Overview
Table 147. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product
Table 148. AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 149. AMAG Pharmaceuticals (CBR) Recent Developments
Table 150. ViaCord Company Details
Table 151. ViaCord Business Overview
Table 152. ViaCord Regenerative Medicine Product
Table 153. ViaCord Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 154. ViaCord Recent Developments
Table 155. CordLife Company Details
Table 156. CordLife Business Overview
Table 157. CordLife Regenerative Medicine Product
Table 158. CordLife Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 159. CordLife Recent Developments
Table 160. Integra LifeSciences Company Details
Table 161. Integra LifeSciences Business Overview
Table 162. Integra LifeSciences Regenerative Medicine Product
Table 163. Integra LifeSciences Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 164. Integra LifeSciences Recent Developments
Table 165. Nuvasive Company Details
Table 166. Nuvasive Business Overview
Table 167. Nuvasive Regenerative Medicine Product
Table 168. Nuvasive Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 169. Nuvasive Recent Developments
Table 170. Cook Biotech Company Details
Table 171. Cook Biotech Business Overview
Table 172. Cook Biotech Regenerative Medicine Product
Table 173. Cook Biotech Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 174. Cook Biotech Recent Developments
Table 175. Japan Tissue Engineering Company Details
Table 176. Japan Tissue Engineering Business Overview
Table 177. Japan Tissue Engineering Regenerative Medicine Product
Table 178. Japan Tissue Engineering Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
Table 179. Japan Tissue Engineering Recent Developments
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Regenerative Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Regenerative Medicine Market Share by Type: 2022 VS 2029
Figure 3. Cell Therapy Features
Figure 4. Tissue Engineering Features
Figure 5. Biomaterial Features
Figure 6. Other Features
Figure 7. Global Regenerative Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Regenerative Medicine Market Share by Application: 2022 VS 2029
Figure 9. Dermatology Case Studies
Figure 10. Cardiovascular Case Studies
Figure 11. CNS Case Studies
Figure 12. Orthopedic Case Studies
Figure 13. Others Case Studies
Figure 14. Regenerative Medicine Report Years Considered
Figure 15. Global Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Regenerative Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Regenerative Medicine Market Share by Region: 2022 VS 2029
Figure 18. Global Regenerative Medicine Market Share by Players in 2022
Figure 19. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2022
Figure 21. North America Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Regenerative Medicine Market Share by Type (2018-2029)
Figure 23. North America Regenerative Medicine Market Share by Application (2018-2029)
Figure 24. North America Regenerative Medicine Market Share by Country (2018-2029)
Figure 25. United States Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Regenerative Medicine Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Regenerative Medicine Market Share by Type (2018-2029)
Figure 29. Europe Regenerative Medicine Market Share by Application (2018-2029)
Figure 30. Europe Regenerative Medicine Market Share by Country (2018-2029)
Figure 31. Germany Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Regenerative Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Regenerative Medicine Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Regenerative Medicine Market Share by Type (2018-2029)
Figure 39. China Regenerative Medicine Market Share by Application (2018-2029)
Figure 40. Asia Regenerative Medicine Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Regenerative Medicine Market Share by Type (2018-2029)
Figure 42. Asia Regenerative Medicine Market Share by Application (2018-2029)
Figure 43. Asia Regenerative Medicine Market Share by Region (2018-2029)
Figure 44. Japan Regenerative Medicine Market